All In MedTech

Device Trial Radar · NCT05252156

eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea

An Open-label Randomized Controlled Trial Assessing the Efficacy of Two Levels of Intraoral Neuromuscular Electrical Stimulation for Moderate Obstructive Sleep Apnea: The ELMO Trial

Last checked: Nov 19, 2026Latest source record: Dec 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

62

Actual

Start

Mar 21, 2022

Primary completion

Oct 26, 2022

Study completion Oct 31, 2022

Sponsor

Lead sponsor
Signifier Medical TechnologiesNot on our public-company list
Sponsor type
Industry
First posted
Feb 23, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with moderate OSA. The study is a multi-center, prospective, open-label, randomized, parallel-arm trial of eXciteOSA (administered at two doses) versus no-therapy for six weeks. Up to 120 participants will be enrolled, in order to randomized n=62.

Conditions

  • Sleep Apnea, Obstructive

Interventions

  • eXciteOSADevice

    eXciteOSA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The difference in the delta-REI (baseline to follow-up) between therapy (Dose-A and Dose-B combined) and no therapyTime frame: Six weeks

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Sleep Disorders Center of Alabama

    Birmingham, Alabama

  • Delta Waves

    Colorado Springs, Colorado

  • Florida Lung & Sleep Associates

    Lehigh Acres, Florida

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.